Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 25 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Lenacapavir with optimised background regimen for treating multidrug resistant human immunodeficiency virus (HIV)-1 infection in people aged 12 years and older	Lenacapavir (GS-6207)	HIV-1 infection	Infectious Disease	2022	View \| Download
IgPro20 for treating dermatomyositis	IgPro20	Dermatomyositis	Dermatology , Infectious Disease	2024	View \| Download
Ibalizumab in combination with other antiretroviral(s) for multidrug-resistant HIV-1 infection	Ibalizumab (Trogarzo; TNX-355)	HIV infection	Infectious Disease	2019	View \| Download
Fostemsavir for HIV-1 infection for heavily treatment-experienced adults	Fostemsavir (GSK3684934; BMS-663068)	HIV-1 infection	Infectious Disease	2019	View \| Download
Ceftobiprole medocaril for treating hospital-acquired pneumonia or community-acquired pneumonia requiring hospitalisation in children	Ceftobiprole medocaril	Community-acquired pneumonia , Hospital-acquired pneumonia	Infectious Disease , Respiratory System	2022	View \| Download
Cefepime-enmetazobactam for treating hospital-acquired pneumonia including ventilator-associated pneumonia	Exblifep (Cefepime;Enmetazobactam)	Hospital-acquired pneumonia , Ventilator-associated pneumonia	Infectious Disease , Respiratory System	2024	View \| Download
Cabotegravir in combination with rilpivirine long acting injection for the treatment of HIV-1 infection	Cabotegravir (GSK1265744) , Rilpivirine hydrochloride (Edurant)	HIV-1 infection	Infectious Disease	2019	View \| Download
Cabotegravir (oral tablet) in combination with rilpivirine (oral tablet) for the short-term treatment of HIV-1 infection	Cabotegravir (GSK1265744) , Rilpivirine hydrochloride (Edurant)	HIV-1 infection	Infectious Disease	2019	View \| Download
Cabotegravir (long-acting injection) for prevention of HIV-1 infection	Cabotegravir (GSK1265744)	HIV-1 infection	Infectious Disease	2023	View \| Download
Bulevirtide for chronic hepatitis delta virus infection	Bulevirtide (Myrcludex B)	Chronic hepatitis D	Hepatology , Infectious Disease	2020	View \| Download